Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts.
Moschetta M, Pretto F, Berndt A, Galler K, Richter P, Bassi A, Oliva P, Micotti E, Valbusa G, Schwager K, Kaspar M, Trachsel E, Kosmehl H, Bani MR, Neri D, Giavazzi R.
Moschetta M, et al. Among authors: giavazzi r.
Cancer Res. 2012 Apr 1;72(7):1814-24. doi: 10.1158/0008-5472.CAN-11-1919. Epub 2012 Mar 5.
Cancer Res. 2012.
PMID: 22392081